Prof. Dr. ENİS ÖZYAR

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler 137

1. MR-guided online adaptive stereotactic body radiotherapy (MRgSBRT) of primary lung tumors and lung oligometastases

Ugurluer G., Dincer N., Mustafayev T. Z., Gungor G., Abacioglu M. U., Sengoz M., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , cilt.201, sa.6, ss.637-644, 2025 (SCI-Expanded) Sürdürülebilir Kalkınma

2. The role of radiotherapy in intracranial hemangiopericytoma/solitary fibrous tumors

Kaydihan N., Yazici G., ERPOLAT Ö. P., Kamer S., ERDEMCİ B., CANYILMAZ E., et al.

STRAHLENTHERAPIE UND ONKOLOGIE , cilt.201, sa.4, ss.431-437, 2025 (SCI-Expanded)

3. Lorlatinib-Induced Blindness: A Rare Entity

Dincer N., Can O., Demir G., ÖZYAR E.

Practical Radiation Oncology , cilt.15, sa.2, ss.120-123, 2025 (SCI-Expanded)

4. Initial experience with MR-guided adaptive spinal stereotactic radiotherapy: a new indication for the MR-linac

Dincer N., Zoto Mustafayev T., Atahan C., GUNGOR G., UĞURLUER G., ABACIOGLU M. U., et al.

Strahlentherapie und Onkologie , 2025 (SCI-Expanded)

5. Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy

Mustafayev T. Z., Turna M., Bolukbasi Y., Tezcanli E. K., Guney Y., DİNÇBAŞ H. F., et al.

BMC CANCER , cilt.24, sa.1, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

6. International Recommendations on Postoperative Management for Potentially Resectable Locally Recurrent Nasopharyngeal Carcinoma

Li J., Blanchard P., Wong C. H. L., Ahn Y. C., Bonomo P., Bresson D., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.120, sa.5, ss.1294-1306, 2024 (SCI-Expanded)

7. Nuclear protein in testis (NUT) midline carcinoma of the larynx: A rare case report of a paediatric patient and literature review

UĞURLUER G., Dincer N., ERŞEN DANYELİ A., Celik L., Guner A. L., Corapcioglu F., et al.

CANCER RADIOTHERAPIE , cilt.28, sa.4, ss.385-389, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

8. Myonecrosis as a rare side effect of stereotactic body radiotherapy for bone metastases: Report of two cases and a comprehensive literature review

Atahan C., UĞURLUER G., Kumbasar B., ÖZYAR E., ATALAR B.

CANCER RADIOTHERAPIE , cilt.28, sa.3, ss.275-279, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

9. Factors influencing local control after MR-guided stereotactic body radiotherapy (MRgSBRT) for adrenal metastases

Ugurluer G., Schneiders F. L., Corradini S., Boldrini L., Kotecha R., Kelly P., et al.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY , cilt.46, 2024 (SCI-Expanded)

10. Awareness Level of Cervical Cancer Patients Referred to Radiation Oncology Outpatient Clinics-A Multicenter Study

Altinok P., Ergen S. A., Guzeloz Capar Z., CANYILMAZ E., Akguen Z., Serin M., et al.

JOURNAL OF LOWER GENITAL TRACT DISEASE , cilt.28, sa.2, ss.143-148, 2024 (SCI-Expanded)

11. Online Adaptive Magnetic Resonance-guided Radiation Therapy for Gynaecological Cancers: Preliminary Results of Feasibility and Outcome

Uğurluer G., Mustafayev T. Z., Gungor G., Abacıoglu M. U., Atalar B., Özyar E.

CLINICAL ONCOLOGY , cilt.36, sa.1, ss.12-20, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

12. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer

Dincer N., Ugurluer G., Mustafayev T. Z., Serkizyan A., Aydin G., Güngör G., et al.

BRACHYTHERAPY , cilt.23, sa.1, ss.18-24, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

13. A Rare Case of BRAF-mutated Metastatic Pleomorphic Xanthoastrocytoma Patient who Developed Radiodermatitis After Receiving Anti-BRAF Treatment

Atahan C., Arslantas E., ERŞEN DANYELİ A., Celik L., Bozkurt G., UĞURLUER G., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.45, sa.8, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

14. The effect of P53 expression and smoking/alcohol in P16 (+) and P16(-) oropharyngeal carcinoma and risk classification: the Turkish Society of Radiation Oncology Head & Neck Study Group 01-002

ÖZKAYA AKAGÜNDÜZ Ö., Etit D., YAZICI G., Veral A., ÇETİNAYAK H. O., Sarioglu S., et al.

ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY , cilt.136, sa.1, ss.80-90, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

15. A multicenter retrospective analysis of patients with nasopharyngeal carcinoma treated in IMRT era from a nonendemic population: Turkish Society for Radiation Oncology Head and Neck Cancer Group Study (TROD 01-001)

Yildirim H. C., Kupik G. E., Mustafayev T. Z., Berber T., Yavuz B., Cetinayak O., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.45, sa.5, ss.1194-1205, 2023 (SCI-Expanded)

16. Neoadjuvant mFOLFIRINOX vs mFOLFIRINOX Plus Radiotherapy in Patients With Borderline Resectable Pancreatic Cancer-The A021501 Trial

Dincer N., UĞURLUER G., ÖZYAR E.

JAMA ONCOLOGY , cilt.9, sa.2, ss.276-277, 2023 (SCI-Expanded)

17. Multi-institutional analysis of cervical esophageal carcinoma patients treated with definitive chemoradiotherapy: TROD 01-005 study

Guler O. C., Oymak E., YAZICI G., ÖZKAYA AKAGÜNDÜZ Ö., ÇETİNAYAK H. O., ERPOLAT Ö. P., et al.

ONCOLOGY RESEARCH , cilt.31, sa.3, ss.299-306, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

18. Radiation therapy using MRI-Linac - the right way to start: a guide for physicians and physicists

ÖZYAR E., Ben-David M. A., Lagerwaard F.

FRONTIERS IN ONCOLOGY , cilt.13, 2023 (SCI-Expanded)

19. A multi-centric evaluation of self-learning GAN based pseudo-CT generation software for low field pelvic magnetic resonance imaging

Prunaretty J., Gungor G., Gevaert T., Azria D., Valdenaire S., Balermpas P., et al.

FRONTIERS IN ONCOLOGY , cilt.13, 2023 (SCI-Expanded)

20. Intervention for Hepatic and Pulmonary Metastases in Breast Cancer Patients: Prospective, Multi-institutional Registry Study-IMET, Protocol MF 14-02

Soran A., Ozbas S., ÖZÇINAR B., Isik A., Dogan L., ŞENOL K., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.10, ss.6327-6336, 2022 (SCI-Expanded)

21. ASO Visual Abstract: Intervention for Hepatic and Pulmonary METastases in Breast Cancer Patients-Prospective, Multi-Institutional Registry Study: IMET; Protocol MF 14-02

Soran A., Ozbas S., ÖZÇINAR B., Isik A., Dogan L., ŞENOL K., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.10, ss.6337-6338, 2022 (SCI-Expanded)

22. Outcomes of carotid sparing intensity-modulated radiotherapy for early stage glottic cancer in 201 patients: Multicenter study of Turkish Radiation Oncology Society/TROD-01-007

Bicakci B. C., Mustafayev T. Z., ÇETİNAYAK H. O., Igdem S., Birgi S. D., Meydan D., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.44, sa.8, ss.1825-1832, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

23. AI surpassing human expert: a multi-centric evaluation for organ at risk delineation

Azria D., Boldrini L., De Ridder M., Fenoglietto P., Gambacorta M. A., Gevaert T., et al.

RADIOTHERAPY AND ONCOLOGY , 2022 (SCI-Expanded)

24. Clinical evaluation of self-learning GAN based pseudo-CT generation software for low field pelvic MR

Fenoglietto P., Gevaert T., Boussaer M., Delasalles E., Ioannidou D., Shreshtha K., et al.

RADIOTHERAPY AND ONCOLOGY , 2022 (SCI-Expanded)

25. AI-based OAR delineation in brain T1w-MRI: Overcoming Inter- and Intra-observer variability

GUNGOR G., Klausner G., Gur G., Serbez I., TEMUR B., Caffaro A., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.170, 2022 (SCI-Expanded)

26. Intervention to hepatic and pulmonary METastases in breast cancer patients: Prospective, multi-institutional registry study-IMET; Protocol MF 14-02

Soran A., Ozbas S., ÖZÇINAR B., IŞIK A., Dogan L., ŞENOL K., et al.

ANNALS OF SURGICAL ONCOLOGY , cilt.29, sa.SUPPL 1, ss.30-31, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

27. Nasopharyngeal cancer in non-endemic areas: Impact of treatment intensity within a large retrospective multicentre cohort

Bossi P., Trama A., Bernasconi A., Grisanti S., Mohamad I., Galiana I. L., et al.

European Journal of Cancer , cilt.159, ss.194-204, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

28. Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (SMART) With Median Biologically Effective Dose of 100 Gy10 for Oligometastases

Chuong M. D., Herrera R., Mustafayev T. Z., GUNGOR G., Ugurluer G., Atalar B., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.111, sa.3, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.

Sayan M., Şahin B., Mustafayev T., Kefelioğlu E., Vergalasova I., Gupta A., et al.

Neurocirugia (Asturias, Spain) , cilt.32, ss.261-267, 2021 (SCI-Expanded)

30. Dosimetric and Clinical Evaluation of Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Treatment of Adrenal Metastases

UĞURLUER G., Serkizyan A., Mustafayev T. Z., ATALAR B., ABACIOGLU M. U., GUNGOR G., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.111, sa.3, 2021 (SCI-Expanded)

31. Human-Level Precision Upper Abdominal OAR Contouring With Anatomically Preserving Deep Learning During Magnetic Resonance Imaging Guided Adaptive Radiotherapy (MRgRT)

GUNGOR G., Michalet M., Lombard A., Roque T., ATALAR B., TEMUR B., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.111, sa.3, 2021 (SCI-Expanded)

32. Long-Term Multi-Institutional Outcomes of 5-Fraction Ablative Stereotactic MR-Guided Adaptive Radiation Therapy (SMART) for Inoperable Pancreas Cancer With Median Prescribed Biologically Effective Dose of 100 Gy(10)

Chuong M. D., Kirsch C., Herrera R., Rubens M., GUNGOR G., Schaff E. M., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.111, sa.3, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

33. Magnetic resonance image-guided hypofractionated ablative radiation therapy for extrahepatic cholangiocarcinoma: Plan adaptation in changing anatomy

Egriboyun S., UĞURLUER G., GUNGOR G., Zoto Mustafayev T., Cicek B., Demir G., et al.

Medical Dosimetry , cilt.46, ss.435-439, 2021 (SCI-Expanded)

34. Long-term multi-institutional outcomes of 5-fraction ablative stereotactic MR-guided adaptive radiation therapy (SMART) for inoperable pancreas cancer with median prescribed biologically effective dose of 100 Gy10

Chuong M., Kirsch C., Herrera R., Rubens M., Gungor G., Schaff E., et al.

International Journal Of Radiation Oncology Biology Physics , cilt.111, sa.3, ss.96, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

35. A pediatric cerebral tumor with MN1 alteration and pathological features mimicking carcinoma metastasis: may the terminology "high grade neuroepithelial tumor with MN1 alteration" still be relevant?

Sari R., Altinoz M. A., ÖZYAR E., Danyeli A., Elmaci I.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery , cilt.37, sa.10, ss.2967-2974, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

36. Stereotactic MR-guided online adaptive radiation therapy for management of pancreatic malignancies

Mustafayev T. Z., UĞURLUER G., GUNGOR G., ATALAR B., Serkizyan A., ABACIOGLU M. U., et al.

RADIOTHERAPY AND ONCOLOGY , 2021 (SCI-Expanded)

37. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia

Clark M. A., Slotman B., ÖZYAR E., Kim M., Itami J., Tallet A., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.161, 2021 (SCI-Expanded)

38. International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma

Ng W. T., Soong Y. L., Ahn Y. C., AlHussain H., Choi H. C. W., Corry J., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.110, sa.3, ss.682-695, 2021 (SCI-Expanded)

39. Time Analysis of Online Adaptive Magnetic Resonance-Guided Radiation Therapy Workflow According to Anatomical Sites.

Güngör G., Serbez İ., Temur B., Gür G., Kayalılar N., Mustafayev T., et al.

Practical radiation oncology , cilt.11, sa.1, 2021 (SCI-Expanded)

40. Magnetic resonance image-guided adaptive stereotactic body radiotherapy for prostate cancer: preliminary results of outcome and toxicity.

Ugurluer G., Atalar B., Zoto M., Gungor G., Aydin G., Sengoz M., et al.

The British journal of radiology , cilt.94, sa.1117, ss.20200696, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

41. Risk of Symptomatic Radiation Necrosis Following Stereotactic Radiosurgery for Brain Metastases

Sayan M., ŞAHİN B., Mustafayev T. Z., Kefelioglu E. S. S., Vergalasova I., Gupta A., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.152, 2020 (SCI-Expanded)

42. Prognostic factors in medically inoperable early stage lung cancer patients treated with stereotactic ablative radiation therapy (SABR): Turkish Radiation Oncology Society Multicentric Study

Sahin B., ATALAR B., Kaytan Saglam E., Akgun Z., ABACIOGLU M. U., Arifoglu A., et al.

CLINICAL RESPIRATORY JOURNAL , cilt.14, sa.11, ss.1050-1059, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

43. Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy.

Sayan M., Serbez I., Teymur B., Gur G., Zoto Mustafayev T., Gungor G., et al.

Frontiers in oncology , cilt.10, ss.1782, 2020 (SCI-Expanded)

44. Corrigendum to "The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases in a single center" [Eur. J. Surg. Oncol. 46/3 (2019) 402-409].

O A., H T., B B., G D., E O., B A., et al.

EUROPEAN JOURNAL OF SURGICAL ONCOLOGY , cilt.46, sa.3, ss.402-409, 2020 (SCI-Expanded)

45. Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors

Atalar B., Mustafayev T., Sio T., Sahin B., Gungor G., Aydın G., et al.

Radiology and Oncology , cilt.54, sa.4, ss.480-487, 2020 (SCI-Expanded)

46. The impact of total neo-adjuvant treatment on nonoperative management in patients with locally advanced rectal cancer: The evaluation of 66 cases

Asoglu O., Tokmak H., BAKIR B., Demir G., Ozyar E., Atalar B., et al.

EJSO , cilt.46, sa.3, ss.402-409, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

47. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience

Sahin B., Zoto M., Gungor G., Aydin G., Yapici B., Atalar B., et al.

CUREUS , cilt.11, sa.12, 2019 (SCI-Expanded)

48. International Guideline on Dose Prioritization and Acceptance Criteria in Radiation Therapy Planning for Nasopharyngeal Carcinoma

Lee A. W., Ng W. T., Pan J. J., Chiang C., Poh S. S., Choi H. C., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.105, sa.3, ss.567-580, 2019 (SCI-Expanded)

49. Strahlentherapie bei Brustkrebs löst kutanen Lupus erythematodes aus.

Öztürk D., Atalar B., Sezer E., Özyar E., Dikicioǧlu Ç.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , cilt.17, ss.832-833, 2019 (SCI-Expanded)

50. Cutaneous lupus erythematosus induced by radiotherapy for breast carcinoma.

Durmaz E., ATALAR B., SEZER E., ÖZYAR E., Cetin E. D.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG , cilt.17, sa.8, ss.832-833, 2019 (SCI-Expanded)

51. Dealing with the gray zones in the management of gastric cancer: The consensus statement of the Istanbul Group

AYTAÇ E., Aslan F., ÇİÇEK B., Erdamar S., Gurses B., GÜVEN K., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , sa.7, ss.584-598, 2019 (SCI-Expanded)

52. Paraganglioma of the head and neck region, treated with radiation therapy, a Rare Cancer Network study

Lassen-Ramshad Y., Ozyar E., ALANYALI S., Poortmans P., van Houtte P., Sohawon S., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.41, sa.6, ss.1770-1776, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

53. Output factors of ionization chambers and solid state detectors for mobile intraoperative radiotherapy (IORT) accelerator electron beams

Gungor G., Aydin G., Mustafayev T. Z., ÖZYAR E.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS , cilt.20, sa.2, ss.13-23, 2019 (SCI-Expanded)

54. Toxicities and Survival after Stereotactic Ablative Radiotherapy (SABR) for Centrally Located Lung Tumors

Atalar B., Mustafayev T., Sio T., Sahin B., Gungor G., Aydin G., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.13, sa.10, 2018 (SCI-Expanded)

55. Results of Stereotactic Radiation Therapy (SABR) in Early Stage Lung Cancer: Turkish Radiation Oncology Group (TROG) Study

Atalar B., KAYTAN SAĞLAM E., Akgun Z., ABACIOGLU M. U., Arifoglu A., Sahin B., et al.

JOURNAL OF THORACIC ONCOLOGY , cilt.13, sa.10, 2018 (SCI-Expanded)

56. Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels

GÜNGÖR G., Aydin G., Ozyar E.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.100, sa.5, ss.1291, 2018 (SCI-Expanded)

57. Treatment outcome and prognostic factors for adult patients with medulloblastoma: The Rare Cancer Network (RCN) experience

ATALAR B., Ozsahin M., Call J., Napieralska A., Kamer S., Villa S., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.127, sa.1, ss.96-102, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

58. Robotic radiosurgery of head and neck paragangliomas: a single institution experience

Tosun I., Atalar B., Sahin B., GÜNGÖR G., Aydin G., Yapici B., et al.

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY , cilt.14, sa.2, 2018 (SCI-Expanded)

59. Concurrent cisplatin and radiotherapy versus cetuximab and radiotherapy, an unsolved problem

Guler O. C., Onal C., Ozyar E.

ANNALS OF ONCOLOGY , cilt.29, sa.3, ss.779, 2018 (SCI-Expanded)

60. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma

Lee A. W., Ng W. T., Pan J. J., Poh S. S., Ahn Y. C., AlHussain H., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.126, sa.1, ss.25-36, 2018 (SCI-Expanded)

61. Improvement of conformal arc plans by using deformable margin delineation method for stereotactic lung radiotherapy

GÜNGÖR G., Demir M., Aydin G., Yapici B., Atalar B., Ozyar E.

JOURNAL OF APPLIED CLINICAL MEDICAL PHYSICS , cilt.19, sa.1, ss.184-193, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

62. Clinical Utility of Epstein-Barr Virus DNA Testing in the Treatment of Nasopharyngeal Carcinoma Patients

Mustafayev T. Z., Ozyar E.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.99, sa.5, ss.1306-1307, 2017 (SCI-Expanded)

63. Correlation between PET/CT primary tumor FDG uptake and lymph node metastases in cervical cancer

UĞURLUER G., ATALAR B., Ikizler H. A. S., Sozer N., Kibar M., Serin M., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.123, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

64. Re-Irradiation of Non-Small Cell Lung Cell Cancer Recurrences with Stereotactic Body Radiotherapy

Atalar B., Sahin B., Gungor G., Aydin G., Yapici B., Ozyar E.

JOURNAL OF THORACIC ONCOLOGY , cilt.12, sa.1, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

65. Prognostic role of negative plasma EBV DNA level in patients with NPC

Ozyar E.

ORAL ONCOLOGY , cilt.63, 2016 (SCI-Expanded)

66. Linguistic Validation of the Turkish Version of the MD Anderson Symptom Inventory - Head and Neck Cancer Module

Gunn G. B., Atalar B., Mendoza T. R., Cleeland C. S., Selek U., Ozyar E., et al.

BALKAN MEDICAL JOURNAL , cilt.33, sa.3, ss.339-343, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

67. Treatment of olfactory neuroblastoma: a new approach

Vucinic N., Eric M., Ergin T., Ozyar E., Vuckovic N.

ACTA NEUROLOGICA BELGICA , cilt.115, sa.2, ss.195-198, 2015 (SCI-Expanded)

68. An unusual case of mammary gland-like carcinoma of vulva: case report and review of literature

Baykal C., Dunder I., Turkmen I. C., Ozyar E.

EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY , cilt.36, sa.3, ss.333-334, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

69. The international network of rare cancers (RCN, Rare Cancer Network)

Mirimanoff R., Thariat J., Beikacemi Y., Villa S., Ozyar E., Krengli M., et al.

BULLETIN DU CANCER , cilt.101, sa.9, ss.778-779, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

70. [RCN, Rare Cancer Network].

Mirimanoff R., Thariat J., Belkacemi Y., Villa S., Ozyar E., Krengli M., et al.

Bulletin du cancer , cilt.101, ss.778-9, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

71. Untitled

Ozyar E., Adler J. R.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.85, sa.1, ss.12, 2013 (SCI-Expanded)

72. High daily fraction dose external radiotherapy for T1 glottic carcinoma: Treatment results and prognostic factors

GÜLTEKİN M., Ozyar E., CENGİZ M., ÖZYİĞİT G., Hayran M., Hosal S., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.34, sa.7, ss.1009-1014, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

73. In regard to Zhou et al "Baseline Serum Lactate Dehydrogenase Levels for Patients Treated With Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma: A Predictor of Poor Prognosis and Subsequent Liver Metastasis" (Int J Radiat Oncol Biol Phys 2012;82:e359-e365)

Ozyar E., Caglar H. B., Atalar B.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.83, sa.2, ss.482-483, 2012 (SCI-Expanded)

74. Dosimetric Comparison of Robotic and Conventional Linac-Based Stereotactic Lung Irradiation in Early-Stage Lung Cancer

Atalar B., Aydin G., Gungor G., Caglar H., Yapici B., Ozyar E.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT , cilt.11, sa.3, ss.249-255, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

75. Use of volumetric modulated arc radiotherapy in patients with early stage glottic cancer

Atalar B., Gungor G., Caglar H., Aydin G., Yapici B., Ozyar E.

TUMORI , cilt.98, sa.3, ss.331-336, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

76. STEREOTACTIC RADIOTHERAPY OF PRIMARY LUNG CANCER AND OTHER TARGETS: RESULTS OF CONSULTANT MEETING OF THE INTERNATIONAL ATOMIC ENERGY AGENCY (INT J RADIAT ONCOL BIOL PHYS 2011;79:660-669)

Atalar B., Caglar H., Ozyar E.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.82, sa.2, ss.521, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

77. Comparisons of static 7 field and dynamic conformal arc techniques for stereotactic lung radiotherapy Stereotaktik akciǧer ışınlamalarında statik 7 alan ve dinamik konformal ark tekniklerinin karşılaştırılması

ATALAR B., Küçükmorkoç E., Doyuran M., Güngör G., Aydin G., Yapici B., et al.

Turk Onkoloji Dergisi , cilt.27, sa.3, ss.111-118, 2012 (SCI-Expanded)

78. Prognostic significance of tumor volume in nasopharyngeal carcinoma

Sarisahin M., Cila A., Ozyar E., YILDIZ F., Turen S.

AURIS NASUS LARYNX , cilt.38, sa.2, ss.250-254, 2011 (SCI-Expanded)

79. Treatment results and prognostic factors in primary thyroid lymphoma patients: a Rare Cancer Network study

Onal C., Li Y. X., Miller R. C., Poortmans P., Constantinou N., Weber D. C., et al.

ANNALS OF ONCOLOGY , cilt.22, sa.1, ss.156-164, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

80. Adult Langerhans cell histiocytosis of bones : A rare cancer network study

Atalar B., Miller R. C., DİNÇBAŞ H. F., Geismar J. H., Micke O., AKYÜREK S., et al.

ACTA ORTHOPAEDICA BELGICA , cilt.76, sa.5, ss.663-668, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

81. Adult langerhans cell histiocytosis of bones : a rare cancer network study.

Atalar B., Miller R. C., Dincbas F. O., Geismar J. H., Micke O., Akyurek S., et al.

Acta orthopaedica Belgica , cilt.76, sa.5, ss.663-8, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

82. Intensity modulated radiotherapy (IMRT) in bilateral retinoblastoma

ATALAR B., ÖZYAR E., GÜNDÜZ K., Gungor G.

RADIOLOGY AND ONCOLOGY , cilt.44, sa.3, ss.194-198, 2010 (SCI-Expanded)

83. PEDIATRIC AND YOUNG ADULT NASOPHARYNGEAL CARCINOMA PATIENTS TREATED WITH PRERADIATION CISPLATIN AND DOCETAXEL CHEMOTHERAPY

VARAN A., Oezyar E., Corapcioglu F., Koeksal Y., Aydin B., Yazici N., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.73, sa.4, ss.1116-1120, 2009 (SCI-Expanded)

84. The treatment of childhood Hodgkin lymphoma: Improved survival in a developing country

Bueyuekpamukcu M., VARAN A., Akyuez C., Atahan L., Oezyar E., Kale G., et al.

ACTA ONCOLOGICA , cilt.48, sa.1, ss.44-51, 2009 (SCI-Expanded)

85. Vaginal high dose rate brachytherapy alone in patients with intermediate- to high-risk stage I endometrial carcinoma after radical surgery.

Atahan I. L., Ozyar E., YILDIZ F., ÖZYİĞİT G., Genc M., Ulger S., et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society , cilt.18, sa.6, ss.1294-9, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

86. Effect of bladder distension on dose distribution of intracavitary brachytherapy for cervical cancer: Three-dimensional computed tomography plan evaluation

CENGİZ M., Gurdalli S., Selek U., YILDIZ F., Saglam Y., Ozyar E., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.70, sa.2, ss.464-468, 2008 (SCI-Expanded) Sürdürülebilir Kalkınma

87. Use of plasma Epstein-Barr virus DNA monitoring as a tumor marker in follow-up of patients with nasopharyngeal carcinoma: Preliminary results and report of two cases

Oezyar E., Gueltekin A., Alp A., Hascelik G., Ugur O., Atahan I. L.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS , cilt.22, sa.3, ss.194-199, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

88. Radiotherapy in the adjuvant setting of cervical carcinoma: treatment, results, and prognostic factors

Atahan I. L., Yildiz F., ÖZYAR E., Pehlivan B., Genc M., KÖSE M. F., et al.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.17, sa.4, ss.813-820, 2007 (SCI-Expanded)

89. Long-term outcome and prognostic factors in patients with cervical carcinoma: a retrospective study

Atahan I. L., Onal C., Ozyar E., Yiliz F., Selek U., Kose F.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER , cilt.17, sa.4, ss.833-842, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

90. Treatment of pediatric nasopharyngeal cancer

Oezyar E.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.29, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

91. Incidence of hypothyroidism after radiotherapy for nasopharyngeal carcinoma

Ulger S., Ulger Z., Yildiz F., Ozyar E.

MEDICAL ONCOLOGY , cilt.24, sa.1, ss.91-94, 2007 (SCI-Expanded)

92. Bimodal age distribution in Hodgkin's disease and nasopharyngeal carcinoma

Barista I., Varan A., Ozyar E.

MEDICAL HYPOTHESES , cilt.68, sa.6, ss.1421, 2007 (SCI-Expanded)

93. Treatment results of 165 pediatric patients with non-metastatic nasopharyngeal carcinoma: A Rare Cancer Network study

ÖZYAR E., Selek U., Laskar S., Uzel O., Anacak Y., Ben-Arush M., et al.

RADIOTHERAPY AND ONCOLOGY , cilt.81, sa.1, ss.39-46, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

94. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: Analysis of 74 cases. A rare cancer network study

Krengli M., Masini L., Kaanders J. H. A. M., Maingon P., Oei S. B., Zouhair A., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.65, sa.3, ss.751-759, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

95. Radiotherapy in the management of Kaposi's sarcoma: Comparison of 8 Gy versus 6 Gy

Yildiz F., Genc M., Akyurek S., Cengiz M., Ozyar E., Selek U., et al.

JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION , cilt.98, sa.7, ss.1136-1139, 2006 (SCI-Expanded)

96. Treatment results of 84 patients with nasopharyngeal carcinoma in childhood

Kupeli S., Varan A., Ozyar E., Atahan I., Yalcin B., Kutluk T., et al.

PEDIATRIC BLOOD & CANCER , cilt.46, sa.4, ss.454-458, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

97. Mold brachytherapy in Bowen's disease: a case report and review of the literature

HÜRMÜZ P., ERSOY EVANS S., Yapici B., Gurdalli S., Saglam Y., ŞAHİN S., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.21, sa.2, ss.102-106, 2006 (SCI-Expanded)

98. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules

Cengiz M., ÖZYAR E., Esassolak M., Altun M., Akmansu M., ŞEN M., et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.63, sa.5, ss.1347-1353, 2005 (SCI-Expanded)

99. Post-operative radiotherapy in advanced laryngeal cancer: effect on local and regional recurrence, distant metastases and second primaries

Yilmaz T., Hosal S., Ozyar E., Akyol F., Gursel B.

JOURNAL OF LARYNGOLOGY AND OTOLOGY , cilt.119, sa.10, ss.784-790, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

100. Trismus as a presenting symptom in nasopharyngeal carcinoma

Ozyar E., Cengiz M., Gurkaynak M., Atahan I.

RADIOTHERAPY AND ONCOLOGY , cilt.77, sa.1, ss.73-76, 2005 (SCI-Expanded)

101. Classical Kaposi's Sarcoma: efficacy of single high dose radiotherapy

Yildiz F., Genc M., Cengiz M., ÖZYAR E., Akbulut S., Hurmuz P., et al.

EJC SUPPLEMENTS , cilt.3, sa.2, ss.351-352, 2005 (SCI-Expanded)

102. Treatment results of 59 young patients with nasopharyngeal carcinoma

Selek U., Ozyar E., Ozyigit G., Varan A., Buyukpamukcu M., Atahan I.

INTERNATIONAL JOURNAL OF PEDIATRIC OTORHINOLARYNGOLOGY , cilt.69, sa.2, ss.201-207, 2005 (SCI-Expanded)

103. Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: Results of single-center study of 45 patients

Altundag O., Gullu I., Altundag K., Yalcin S., Ozyar E., Cengiz M., et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK , cilt.27, sa.1, ss.15-21, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

104. Unusual, hypersensitivity to radiation therapy in a patient with dyskeratosis congenita syndrome

Cengiz M., Ozyar E., Atahan I., Celebioglu B.

ORAL ONCOLOGY , cilt.40, sa.7, ss.758-759, 2004 (SCI-Expanded)

105. Non-metastatic stage IV nasopharyngeal carcinoma patients: analysis of the pattern of relapse and survival

Ozyar E., Gurkaynak M., Yildiz F., Atahan I.

RADIOTHERAPY AND ONCOLOGY , cilt.72, sa.1, ss.71-77, 2004 (SCI-Expanded)

106. Prognostic role of Ebstein-Barr virus latent membrane protein-1 and Interleukin-10 expression in patients with nasopharyngeal carcinoma

Ozyar E., Ayhan A., Korcum A., Atahan I.

CANCER INVESTIGATION , cilt.22, sa.4, ss.483-491, 2004 (SCI-Expanded)

107. Salvage ifosfamide-doxorubicin chemotherapy in patients with recurrent nasopharyngeal carcinoma pretreated with cisplatin-based chemotherapy

Altundag K., Aksoy S., Gullu I., Altundag O., Ozyar E., Yalcin S., et al.

MEDICAL ONCOLOGY , cilt.21, sa.3, ss.211-215, 2004 (SCI-Expanded)

108. Frequency of skeletal metastases in nasopharyngeal carcinoma after initiation of therapy: should bone scans be used for follow-up?

Caglar M., Ceylan E., Ozyar E.

NUCLEAR MEDICINE COMMUNICATIONS , cilt.24, sa.12, ss.1231-1236, 2003 (SCI-Expanded) Sürdürülebilir Kalkınma

109. Waldeyer's ring lymphomas - Treatment results and prognostic factors

Gurkaynak M., Cengiz M., AKYÜREK S., ÖZYAR E., Atahan I., Tekuzman G.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.26, sa.5, ss.437-440, 2003 (SCI-Expanded)

110. Mold brachytherapy can be an optional technique for total scalp irradiation

Ozyar E., Gurdalli S.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.54, sa.4, ss.1286, 2002 (SCI-Expanded)

111. Is there a survival benefit to adjuvant radiotherapy in high-risk surgical stage I endometrial cancer?

Ayhan A., Taskiran C., Celik C., Guney I., Yuce K., Ozyar E., et al.

GYNECOLOGIC ONCOLOGY , cilt.86, sa.3, ss.259-263, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

112. Adjuvant high-dose-rate brachytherapy after external beam radiotherapy in nasopharyngeal carcinoma

Ozyar E., Yildz F., Akyol F., Atahan I.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.52, sa.1, ss.101-108, 2002 (SCI-Expanded) Sürdürülebilir Kalkınma

113. Outcome of abducens nerve paralysis in patients with nasopharyngeal carcinoma

Ilhan O., Sener E., Ozyar E.

EUROPEAN JOURNAL OF OPHTHALMOLOGY , cilt.12, sa.1, ss.55-59, 2002 (SCI-Expanded)

114. Radiotherapy in the management of Kasabach-Merritt syndrome: A case report

Atahan I., Cengiz M., Ozyar E., Gurkaynak M.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.18, sa.7, ss.471-476, 2001 (SCI-Expanded)

115. In regard to Altun et al.

Ozyar E.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.49, sa.3, ss.900-901, 2001 (SCI-Expanded)

116. Malignancy in Behcet's disease: A report of 13 cases and a review of the literature

Cengiz M., Altundag M., Zorlu A., Gullu I., Ozyar E., Atahan I.

CLINICAL RHEUMATOLOGY , cilt.20, sa.4, ss.239-244, 2001 (SCI-Expanded)

117. Two cases of Stevens-Johnson syndrome: toxic epidermal necrolysis possibly induced by amifostine during radiotherapy

Atahan I., Ozyar E., Sahin S., Yildiz F., Yalcin B., Karaduman A.

BRITISH JOURNAL OF DERMATOLOGY , cilt.143, sa.5, ss.1072-1073, 2000 (SCI-Expanded)

118. Caution on the use of altered fractionation for nasopharyngeal carcinoma - comment

Ozyar E., Atahan I.

RADIOTHERAPY AND ONCOLOGY , cilt.54, sa.3, ss.283-284, 2000 (SCI-Expanded)

119. Organ preservation by induction chemotherapy plus radiotherapy in locally advanced larynx and hypopharynx cancers: Preliminary results.

Gullu Y., Altundag M., Yalcin S., Altundag O., Tekuzman G., Ozyar E., et al.

ANNALS OF ONCOLOGY , cilt.11, ss.94, 2000 (SCI-Expanded) Sürdürülebilir Kalkınma

120. High dose rate mold brachytherapy of early gingival carcinoma: A clinical report

Cengiz M., Ozyar E., Ersu B., Akyol F., Atahan I.

JOURNAL OF PROSTHETIC DENTISTRY , cilt.82, sa.5, ss.512-514, 1999 (SCI-Expanded)

121. Acute phase response during radiotherapy

Cengiz M., Akbulut S., Ozturk D., Ozyar E., Atahan I.

EUROPEAN JOURNAL OF CANCER , cilt.35, 1999 (SCI-Expanded)

122. Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma

Ozyar E., Yildiz F., Akyol F., Atahan I.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , cilt.44, sa.5, ss.1079-1087, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

123. Sucralfate in the prevention of radiation-induced oral mucositis

Cengiz M., Ozyar E., Ozturk D., Akyol F., Atahan I., Hayran M.

JOURNAL OF CLINICAL GASTROENTEROLOGY , cilt.28, sa.1, ss.40-43, 1999 (SCI-Expanded) Sürdürülebilir Kalkınma

124. Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia

Uzal D., Ozyar E., Hayran M., Zorlu F., Atahan L., Yetkin S.

RADIOTHERAPY AND ONCOLOGY , cilt.48, sa.1, ss.29-32, 1998 (SCI-Expanded)

125. Choroid metastasis of undifferentiated nasopharyngeal carcinoma

Ozyar E., Kiratli H., Akbulut S., Uzal D., Atahan I.

JOURNAL OF LARYNGOLOGY AND OTOLOGY , cilt.112, sa.7, ss.667-669, 1998 (SCI-Expanded)

126. A hinged flange radiation carrier for the scalp: A clinical report

Ersu B., Hekimoglu C., Ozyar E., Aslan Y.

JOURNAL OF PROSTHETIC DENTISTRY , cilt.79, sa.4, ss.369-371, 1998 (SCI-Expanded)

127. Basal cell carcinomas developing in a case of medulloblastoma associated with Gorlin's syndrome

Atahan I., Yildiz F., Ozyar E., Uzal D., Zorlu F.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.15, sa.2, ss.187-191, 1998 (SCI-Expanded)

128. Monitoring response to therapy with thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma

Kostakoglu L., Uysal U., Ozyar E., Hayran M., Uzal D., Demirkazik F., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.38, sa.7, ss.1009-1014, 1997 (SCI-Expanded)

129. A comparative study of technetium-99m sestamibi and technetium-99m tetrofosmin single-photon tomography in the detection of nasopharyngeal carcinoma

Kostakoglu L., Uysal U., Ozyar E., Demirkazik F., Hayran M., Atahan L., et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE , cilt.24, sa.6, ss.621-628, 1997 (SCI-Expanded)

130. Kaposi's sarcoma: The efficacy of a single fraction of 800 cGy

Yildiz F., Ozyar E., Uzal D., Sahin S., Atahan I.

DERMATOLOGY , cilt.195, sa.2, ss.142-144, 1997 (SCI-Expanded) Sürdürülebilir Kalkınma

131. Pre- and post-therapy thallium-201 and technetium-99m-sestamibi SPECT in nasopharyngeal carcinoma

Kostakoglu L., Uysal U., Ozyar E., Elahi N., Hayran M., Uzal D., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.37, sa.12, ss.1956-1962, 1996 (SCI-Expanded)

132. Determination of the diagnostic potentials of Tl-201 and Tc-99m-Sestamibi (MIBI) during pre- and post-therapy evaluation in nasopharyngeal carcinoma.

Kostakoglu L., Uysal U., Ozyar E., Hayran M., Uzal D., Caner B., et al.

JOURNAL OF NUCLEAR MEDICINE , cilt.37, sa.5, ss.1153, 1996 (SCI-Expanded)

133. Major toxicity of cisplatin, fluorouracil, and leucovorin following chemoradiotherapy in patients with nasopharyngeal carcinoma

Celik I., Kars A., Ozyar E., Tekuzman G., Atahan L., Firat D.

JOURNAL OF CLINICAL ONCOLOGY , cilt.14, sa.3, ss.1043-1044, 1996 (SCI-Expanded)

134. A CASE OF MUCOEPIDERMOID CARCINOMA OF THE PAROTID-GLAND DEVELOPING IN A CHILD AFTER THE TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA

ATAHAN I., AYHAN A., OZYAR E., ERTOY D., GURKAYNAK M.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.12, sa.4, ss.403-405, 1995 (SCI-Expanded)

135. RESULTS OF RADIOTHERAPY IN CRANIOPHARYNGIOMAS ANALYZED BY THE LINEAR-QUADRATIC MODEL

GURKAYNAK M., OZYAR E., ZORLU F., AKYOL F., ATAHAN I.

ACTA ONCOLOGICA , cilt.33, sa.8, ss.941-943, 1994 (SCI-Expanded)

136. RESULTS OF POSTOPERATIVE OR EXCLUSIVE RADIOTHERAPY IN GRADE-I AND GRADE-II CEREBELLAR ASTROCYTOMA PATIENTS

AKYOL F., ATAHAN I., ZORLU F., GURKAYNAK M., ALANYALI H., OZYAR E.

RADIOTHERAPY AND ONCOLOGY , cilt.23, sa.4, ss.245-248, 1992 (SCI-Expanded)

137. A LOCALIZED HYPERSENSITIVITY REACTION TO CO-TRIMOXAZOLE IN A PREVIOUSLY IRRADIATED FIELD SIMULATING A RECALL PHENOMENON

ATAHAN I., AKYOL F., GURKAYNAK M., ALANYALI H., OZYAR E.

BRITISH JOURNAL OF RADIOLOGY , cilt.62, sa.744, ss.1107-1108, 1989 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler 28

1. A National Survey on the Awareness of Artificial Intelligence Technologies Among Radiation Oncologists- Turkish Society of Radiation Oncology Artificial Intelligence and Information Technology Group Study

Kirakli E. K. O. R. K. M. A. Z., Gursel S. B., Erkal E. Y. I. R. M. I. B. E. S. O. G. L. U., ETİZ D., ÖZYAR E.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.38, ss.1-8, 2023 (ESCI)

2. Current Status of Stereotactic Radiotherapy in Turkiye: Turkish Society for Radiation Oncology Stereotactic Radiotherapy Study Group 10-006 Survey

DURU BİRGİ S., Turna M., Caglar H. B., Yildirim B. A., YÜCE SARI S., AKYÜREK S., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.38, sa.4, ss.407-416, 2023 (ESCI) Sürdürülebilir Kalkınma

3. Multi-Institutional Outcomes of Stereotactic Magnetic Resonance Image Guided Adaptive Radiation Therapy With a Median Biologically Effective Dose of 100 Gy(10) for Non-bone Oligometastases

Kutuk T., Herrera R., Mustafayev T. Z., Gungor G., Ugurluer G., Atalar B., et al.

ADVANCES IN RADIATION ONCOLOGY , cilt.7, sa.6, 2022 (ESCI)

4. Magnetic Resonance Imaging-Guided Radiation Therapy for Early-Stage Gastric Mucosa-Associated Lymphoid Tissue Lymphoma

Dincer N., Ugurluer G., Gungor G., Zoto Mustafayev T., Atalar B., Ozyar E.

CUREUS JOURNAL OF MEDICAL SCIENCE , sa.9, 2022 (ESCI)

5. Psychosocial Impact of the War in Ukraine on Pediatric Cancer Patients and Their Families Receiving Oncological Care Outside Their Country at the Onset of Hostilities.

Uğurluer G., Özyar E., Corapcioglu F., Miller R. C.

Advances in radiation oncology , cilt.7, sa.4, ss.100957, 2022 (Scopus) Sürdürülebilir Kalkınma

6. Magnetic Resonance Image-Guided Hypofractionated Ablative Radiation Therapy for Hepatocellular Carcinoma With Tumor Thrombus Extending to the Right Atrium

Dincer N., UĞURLUER G., Mustafayev T. Z., Gungor G., ATALAR B., GÜVEN K., et al.

CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.14, sa.4, 2022 (ESCI)

7. Magnetic Resonance Imaging-Guided Online Adaptive Lattice Stereotactic Body Radiotherapy in Voluminous Liver Metastasis: Two Case Reports

Dincer N., UĞURLUER G., Korkmaz L., Serkizyan A., ATALAR B., Gungor G., et al.

CUREUS JOURNAL OF MEDICAL SCIENCE , cilt.14, sa.4, 2022 (ESCI)

8. The potential role of MR-guided adaptive radiotherapy in pediatric oncology: Results from a SIOPE-COG survey

Seravalli E., Kroon P. S., Buatti J. M., Hall M. D., Mandeville H. C., Marcus K. J., et al.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY , cilt.29, ss.71-78, 2021 (Hakemli Dergi)

9. Magnetic resonance image-guided stereotactic body radiation therapy for liver rhabdoid tumor in infancy: A case report

Egriboyun S., UĞURLUER G., Corapcioglu F. V., Celik L., GUNGOR G., ATALAR B., et al.

Journal of Medical Imaging and Radiation Sciences , cilt.52, ss.305-311, 2021 (Hakemli Dergi)

10. Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience

UĞURLUER G., Mustafayev T. Z., GUNGOR G., ATALAR B., ABACIOGLU M. U., ŞENGÖZ K. M., et al.

RADIATION ONCOLOGY JOURNAL , cilt.39, sa.1, ss.33-40, 2021 (Hakemli Dergi)

11. Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response.

Sayan M., Mustafayev T. Z., Balmuk A., Mamidanna S., Kefelioglu E. S. S., GUNGOR G., et al.

Radiation oncology journal , cilt.38, sa.3, ss.176-180, 2020 (Hakemli Dergi)

12. Magnetic Resonance–Guided Radiation Therapy to Boost Cervical Cancer When Brachytherapy Is Not Available: A Case Report

Sayan M., Mustafayev T. Z., ATALAR B., GÜNGÖR G., ÖZYAR E.

Advances in Radiation Oncology , cilt.5, sa.5, ss.1066-1070, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

13. Multichannel Film Dosimetry for Quality Assurance of Intensity Modulated Radiotherapy Treatment Plans Under 0.35 T Magnetic Field

Gungor G., Korkmaz L., Kayalilar N., Aydin G., Yapici B., Mustafayev T. Z., et al.

CUREUS , cilt.12, 2020 (Hakemli Dergi)

14. Evaluation of response to stereotactic radiosurgery in patients with radioresistant brain metastases

Sayan M., Zoto M., Sahin B., Kefelioglu E., Wang S., Kurup V., et al.

RADIATION ONCOLOGY JOURNAL , cilt.37, sa.4, ss.265-270, 2019 (Hakemli Dergi)

15. Nüks Rektum Kanserinde İntraoperatif Radyoterapi

BİLGİN İ. A., AYTAÇ E., ERENLER B. İ., ŞAHİN B., ATALAR B., BEŞE F. N., et al.

Acıbadem Sağlık Bilimleri Dergisi , cilt.10, sa.3, ss.473-477, 2019 (Hakemli Dergi) Sürdürülebilir Kalkınma

16. Nazofarenks kanserinde EBV DNA : Tanı, prognoz,tayini, tedavi kararı ve takipte yeri

Özyar E., Uğurluer G.

Kanser Gündemi , cilt.7, sa.2, ss.34-41, 2019 (Hakemsiz Dergi) Sürdürülebilir Kalkınma

17. Non-small Cell Lung Cancer with Multiple Brain Metastases Treated with Radiosurgery and Erlotinib: A Case Report

Sahin B., Mustafayev T., Aydin G., GÜNGÖR G., Yapici B., Atalar B., et al.

CUREUS , cilt.9, sa.12, 2017 (Hakemli Dergi)

18. Serviks Kanserinde Türkiyedeki Sağkalım: 16 Merkezin ortak sonuçları

AKMANSU M., AKSU M. G., AKSU M. G., ALANYALI S., ARAS A. B., ASLAY I., et al.

TURKISH JOURNAL of ONCOLOGY , cilt.32, sa.1, ss.7-10, 2017 (ESCI)

19. Serviks Kanserinde Türkiye’deki Sağkalım: 16 Merkezin Ortak Sonuçları

AKMANSU M., AKSU M. G., AKSU M. G., ALANYALI S., ARAS A. B., ASLAY I., et al.

Turkish Journal of Oncology , cilt.32, sa.1, ss.7-10, 2017 (Hakemli Dergi)

20. Serviks Kanser,nde Türkiye’xxdeki sağkalım Sonuçları

AKMANSU M., AKSU M. G., AKSU M. G., ALANYALI S., ARAS A. B., aslay I., et al.

Turkish Journal Of Oncology , cilt.32, sa.Supp1, ss.7-10, 2017 (Hakemli Dergi)

21. Carotid blowout syndrome after intensity-modulated radiation therapy: A case report

Sahin B., Atalar B., Yakupoglu A., Ozyar E.

MARMARA MEDICAL JOURNAL , cilt.30, sa.2, ss.124-129, 2017 (Hakemli Dergi)

22. Akciğer Kanseri SBRT Uygulamalarının RTOG 0915 Protokolüne Uygun Doz Sınırlamalarına Göre Oluşturulan 3B Konformal Ark ve VMAT SBRT Planlarının Karşılaştırılması

BAŞLANGIÇ B., GÜNGÖR G., AYDIN G., ULUER M., KARADEMİR M., YAPICI B., et al.

Acıbadem Üniversitesi Sağlık Bilimleri Dergisi , cilt.8, sa.3, ss.146-149, 2017 (Hakemli Dergi)

23. The present and future opportunities of the Rare Cancer Network an international consortium for advancement of oncologic care

Sio T., Mirimanoff R., ÖZYAR E., Belkacemi Y., Miller R., Villa S., et al.

Rare Tumors , 2015 (Hakemli Dergi) Sürdürülebilir Kalkınma

24. The present and future opportunities of the Rare Cancer Network: an international consortium for advancement of oncologic care

Sio T. T., Mirimanoff R., ÖZYAR E., Belkacemi Y., Miller R. C., Villa S., et al.

RARE TUMORS , cilt.7, sa.3, ss.136-141, 2015 (ESCI)

25. Acıbadem Sağlık Grubu ve Acıbadem Üniversitesi Hastaneleri radyasyon onkolojisi bölümleri jinekolojik radyoterapi ve brakiterapi protokolleri

GARİPAĞAOĞLU M., TEZCANLI TJON A MEEUW E. K., ATALAR B., UĞURLUER G., UÇAR K., SOZER N., et al.

Türk Onkoloji Dergisi , 2012 (Hakemli Dergi)

26. Protocols for Gynecologic Radiotherapy and Brachytherapy in Acibadem Health Group and Acibadem University Hospitals Departments of Radiation Oncology VE4DH001A

Garipagaoglu M., Tezcanli E. K., Atalar B., Ugurluel G., Ucar K., Sozen N., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.27, sa.1, ss.1-3, 2012 (ESCI)

27. Retrospective analysis of patients treated in the Istanbul CyberKnife Coalition Centers

ATALAR B., Kocak M., Ozseker N., Kucuk N., Dagoglu N., ÖZYAR E., et al.

TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , cilt.26, sa.3, ss.101-107, 2011 (Hakemli Dergi) Sürdürülebilir Kalkınma

28. T4N0M0 nasopharyngeal carcinoma patients: do they have a distinct tumor biology?

Atasoy B. M., Ozyar E., Akman F., Esassolak M., Abacioǧlu U.

Kulak burun boǧaz ihtisas dergisi : KBB = Journal of ear, nose, and throat , cilt.20, sa.2, ss.89-96, 2010 (Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 53

1. Efficacy and Safety of Magnetic Resonance-Guided Online Adaptive Stereotactic Radiotherapy in Oligometastatic Gynecologic Malignancies: A Multi -Institutional Outcomes Study

Cerbon D. A., ÖZYAR E., UĞURLUER G., Tadross M., Rivera A., Albuquerque K. V., et al.

66th International Conference on American-Society-for-Radiation-Oncology (ASTRO), Washington, Kiribati, 29 Eylül - 02 Ekim 2024, (Özet Bildiri)

2. Therapy Dogs Supported Radiotherapy in Cancer Patients Treated with MR Linac Preliminary Results

Kucuktulu E., ATALAR B., TOPBAŞ M., Bilir B., Bicakci A., YILMAZ K. B., et al.

66th International Conference on American-Society-for-Radiation-Oncology (ASTRO), Washington, Kiribati, 29 Eylül - 02 Ekim 2024, (Özet Bildiri)

3. Breast cancer annotation across genders

Costea M., Colombo L., GUNGOR G., Klausner G., Clavier J., Leduc N., et al.

Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Glasgow, İngiltere, 3 - 07 Mayıs 2024, (Özet Bildiri)

4. Dosimetric Comparison of High Dose Rate Brachytherapy vs MR-Guided SBRT Boost for Cervical Cancer

DİNCER N., UĞURLUER G., Mustafayev T. Z., Serkizyan A., AYDIN G., GUNGOR G., et al.

Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Vienna, Avusturya, 12 - 16 Mayıs 2023, (Özet Bildiri)

5. Benefit of Magnetic Resonance guided adaptive radiotherapy for treatment of pancreatic lesions

Mustafayev T. Z., UĞURLUER G., Serkizyan A., Gungor G., ATALAR B., ÖZYAR E.

Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO), Vienna, Avusturya, 12 - 16 Mayıs 2023, (Özet Bildiri)